PetCaseFinder

Peer-reviewed veterinary case report

Evaluation of a point-of-care hematology analyzer for use in dogs and cats receiving chemotherapeutic treatment.

Journal:
Journal of the American Veterinary Medical Association
Year:
2008
Authors:
Lara-Garcia, Ana et al.
Affiliation:
Department of Veterinary Clinical Sciences · United States

Plain-English summary

This study looked at how well a portable blood analyzer works for measuring certain blood components in dogs and cats undergoing chemotherapy. Researchers compared the results from this point-of-care device with those from a more traditional lab method in 105 dogs and 25 cats. They found that the portable analyzer was very reliable for checking white blood cell counts, neutrophils (a type of white blood cell), and hematocrit (the proportion of blood made up of red blood cells). It was particularly good at detecting low white blood cell counts, low neutrophil counts, and anemia (low red blood cell levels), although it was less effective at spotting low platelet counts in cats. Overall, the portable analyzer proved to be a useful tool for monitoring the health of pets receiving chemotherapy.

Abstract

OBJECTIVE: To compare WBC, neutrophil, and platelet counts and Hct values obtained with a point-of-care hematology analyzer with values obtained by a reference method for dogs and cats receiving chemotherapy. DESIGN: Cross-sectional study. ANIMALS: 105 dogs and 25 cats undergoing chemotherapy. PROCEDURES: Blood samples were analyzed with a point-of-care hematology analyzer and with an impedance- and laser-based analyzer with manual differential WBC counts. Results for WBC, neutrophil, and platelet counts and Hct were compared. Sensitivity and specificity of the point-of-care analyzer to detect leukopenia, neutropenia, and anemia were calculated. RESULTS: 554 canine and 96 feline blood samples were evaluated. Correlation coefficients for dogs and cats, respectively, were 0.92 and 0.95 for total WBC count, 0.91 and 0.88 for neutrophil count, 0.95 and 0.92 for Hct, and 0.93 and 0.71 for platelet count. Sensitivity and specificity, respectively, of the point-of-care analyzer to detect leukopenia were 100% and 75% for dogs and 100% and 68% for cats; to detect neutropenia were 80% and 97% for dogs and 100% and 80% for cats; to detect anemia were 100% and 80% for dogs and 100% and 66% for cats; and to detect thrombocytopenia were 86% and 95% for dogs and 50% and 87% for cats. CONCLUSIONS AND CLINICAL RELEVANCE: The point-of-care analyzer was reliable for monitoring CBCs of dogs and cats receiving chemotherapy. It had good to excellent correlation for WBC and neutrophil counts and Hct and accurately detected leukopenia, neutropenia, and anemia. Sensitivity of the analyzer for detecting thrombocytopenia was lower but acceptable.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication: https://pubmed.ncbi.nlm.nih.gov/18479238/